These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 14586044)

  • 1. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.
    Culpitt SV; Rogers DF; Fenwick PS; Shah P; De Matos C; Russell RE; Barnes PJ; Donnelly LE
    Thorax; 2003 Nov; 58(11):942-6. PubMed ID: 14586044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.
    Knobloch J; Hag H; Jungck D; Urban K; Koch A
    Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):138-43. PubMed ID: 21447053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Culpitt SV; Rogers DF; Shah P; De Matos C; Russell RE; Donnelly LE; Barnes PJ
    Am J Respir Crit Care Med; 2003 Jan; 167(1):24-31. PubMed ID: 12406856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
    J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.
    Armstrong J; Sargent C; Singh D
    Clin Exp Immunol; 2009 Oct; 158(1):74-83. PubMed ID: 19737233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.
    Knobloch J; Wahl C; Feldmann M; Jungck D; Strauch J; Stoelben E; Koch A
    Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):202-9. PubMed ID: 23981542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
    Wang XL; Li T; Li JH; Miao SY; Xiao XZ
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
    Gerlach K; Köhler-Bachmann S; Jungck D; Körber S; Yanik S; Knoop H; Wehde D; Rheinländer S; Walther JW; Kronsbein J; Knobloch J; Koch A
    Eur J Pharmacol; 2015 Dec; 768():123-30. PubMed ID: 26526351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease.
    Li L; Wang Y; Gao W; Yuan C; Zhang S; Zhou H; Huang M; Yao X
    J Biol Chem; 2015 Nov; 290(46):27890-900. PubMed ID: 26385922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
    Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M
    J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
    Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
    Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).
    Barnawi J; Tran H; Jersmann H; Pitson S; Roscioli E; Hodge G; Meech R; Haberberger R; Hodge S
    PLoS One; 2015; 10(10):e0122771. PubMed ID: 26485657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.
    Lea SR; Reynolds SL; Kaur M; Simpson KD; Hall SR; Hessel EM; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():771-780. PubMed ID: 29535517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD).
    Eapen MS; Hansbro PM; McAlinden K; Kim RY; Ward C; Hackett TL; Walters EH; Sohal SS
    Sci Rep; 2017 Oct; 7(1):13392. PubMed ID: 29042607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma.
    John M; Lim S; Seybold J; Jose P; Robichaud A; O'Connor B; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1998 Jan; 157(1):256-62. PubMed ID: 9445307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.
    Liu HM; Liu YT; Zhang J; Ma LJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):496-504. PubMed ID: 28786060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of adiponectin in cigarette smoke-activated alveolar macrophage through the COX-2/PGE
    Wang D; Zhang S; Liu B; Wang B; He S; Zhang R
    Cytokine; 2020 Sep; 133():155148. PubMed ID: 32505095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.